Gian Poalo Fadini (G P Fadini, Gian Paolo Fadini)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 122

Top Venues

Diabetes, obesity & metabolism

Cardiovascular diabetology

Diabetes therapy : research, treatment and education of diabetes and related disorders

Journal of endocrinological investigation

University of Padova

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Padova Feb 01 2016

Italy

Associate Professor :: Department of Medicine

Publications

Guillermo E Umpierrez, Georgia M Davis, Nuha A ElSayed, Gian Poalo Fadini, Rodolfo J Galindo, Irl B Hirsch, David C Klonoff, Rozalina Grubina McCoy, Shivani Misra, Robert A Gabbay, Raveendhara R Bannuru, Ketan K Dhatariya
Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia 67 (8) (2024)
Gian Poalo Fadini, Raffaella Buzzetti, Dario Pitocco, Elena Tortato, Alessia Scatena, Olga Lamacchia, Giusi Lastoria, Lucia Simoni, Agostino Consoli, null null
IDegLira for the real-world treatment of type 2 diabetes in Italy. Final results from the REX observational study. Diabetes, obesity & metabolism 26 (5) (2024)
B M Bonora, G Russo, F Leonetti, M Strazzabosco, L Nollino, G Aimaretti, A Giaccari, F Broglio, A Consoli, A Avogaro, Gian Poalo Fadini, null null
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study. Journal of endocrinological investigation 47 (6) (2024)
Guillermo E Umpierrez, Georgia M Davis, Nuha A ElSayed, Gian Poalo Fadini, Rodolfo J Galindo, Irl B Hirsch, David C Klonoff, Rozalina Grubina McCoy, Shivani Misra, Robert A Gabbay, Raveendhara R Bannuru, Ketan K Dhatariya
Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia (2024)
Riccardo Candido, Chiara Di Loreto, Paolo Desenzani, Paola Pantanetti, Cristina Romano, Silvio Settembrini, Sebastiano Bruno Solerte, Gian Poalo Fadini
Suitability and Usefulness of a Flexible Dosing Timing of Oral Semaglutide to Maximize Benefit in Clinical Practice: An Expert Panel. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
B M Bonora, G Russo, F Leonetti, M Strazzabosco, L Nollino, G Aimaretti, A Giaccari, F Broglio, A Consoli, A Avogaro, Gian Poalo Fadini, null null
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study. Journal of endocrinological investigation 47 (6) (2024)
Guillermo E Umpierrez, Georgia M Davis, Nuha A ElSayed, Gian Poalo Fadini, Rodolfo J Galindo, Irl B Hirsch, David C Klonoff, Rozalina Grubina McCoy, Shivani Misra, Robert A Gabbay, Raveendhara R Bannuru, Ketan K Dhatariya
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes care 47 (8) (2024)
Guillermo E Umpierrez, Georgia M Davis, Nuha A ElSayed, Gian Poalo Fadini, Rodolfo J Galindo, Irl B Hirsch, David C Klonoff, Rozalina Grubina McCoy, Shivani Misra, Robert A Gabbay, Raveendhara R Bannuru, Ketan K Dhatariya
Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia (2024)
Riccardo Candido, Chiara Di Loreto, Paolo Desenzani, Paola Pantanetti, Cristina Romano, Silvio Settembrini, Sebastiano Bruno Solerte, Gian Poalo Fadini
Suitability and Usefulness of a Flexible Dosing Timing of Oral Semaglutide to Maximize Benefit in Clinical Practice: An Expert Panel. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Gian Poalo Fadini, Benedetta Maria Bonora, Mariangela Ghiani, Roberto Anichini, Elena Melchionda, Bruno Fattor, Stefano Fazion, Giancarla Meregalli, Andrea Giaccari, Angelo Avogaro, Agostino Consoli, null null
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts. Diabetes, obesity & metabolism 26 (6) (2024)
Gian Poalo Fadini, Benedetta Maria Bonora, Mariangela Ghiani, Roberto Anichini, Elena Melchionda, Bruno Fattor, Stefano Fazion, Giancarla Meregalli, Andrea Giaccari, Angelo Avogaro, Agostino Consoli, null null
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts. Diabetes, obesity & metabolism (2024)
B M Bonora, G Russo, F Leonetti, M Strazzabosco, L Nollino, G Aimaretti, A Giaccari, F Broglio, A Consoli, A Avogaro, Gian Poalo Fadini, null null
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study. Journal of endocrinological investigation 47 (6) (2024)
Guillermo E Umpierrez, Georgia M Davis, Nuha A ElSayed, Gian Poalo Fadini, Rodolfo J Galindo, Irl B Hirsch, David C Klonoff, Rozalina Grubina McCoy, Shivani Misra, Robert A Gabbay, Raveendhara R Bannuru, Ketan K Dhatariya
Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia 67 (8) (2024)
Marella Marassi, Mario Luca Morieri, Viola Sanga, Giulio Ceolotto, Angelo Avogaro, Gian Poalo Fadini
The Elusive Nature of ABCC8-related Maturity-Onset Diabetes of the Young (ABCC8-MODY). A Review of the Literature and Case Discussion. Current diabetes reports 24 (9) (2024)
Gian Poalo Fadini, Raffaella Buzzetti, Dario Pitocco, Elena Tortato, Alessia Scatena, Olga Lamacchia, Giusi Lastoria, Lucia Simoni, Agostino Consoli, null null
IDegLira for the real-world treatment of type 2 diabetes in Italy. Final results from the REX observational study. Diabetes, obesity & metabolism (2024)
Lars Norgren, Norbert Weiss, Sigrid Nikol, John C Lantis, Manesh R Patel, Robert J Hinchliffe, Holger Reinecke, Hans Dieter Volk, Petra Reinke, Gian Poalo Fadini, Racheli Ofir, Daniel Rothenstein, Nitsan Halevy, Mitko Karagjozov, John H Rundback
PACE: randomized, controlled, multicentre, multinational, phase III study of PLX-PAD for critical limb ischaemia in patients unsuitable for revascularization: randomized clinical trial. The British journal of surgery 111 (2) (2024)
Riccardo Candido, Chiara Di Loreto, Paolo Desenzani, Paola Pantanetti, Cristina Romano, Silvio Settembrini, Sebastiano Bruno Solerte, Gian Poalo Fadini
Suitability and Usefulness of a Flexible Dosing Timing of Oral Semaglutide to Maximize Benefit in Clinical Practice: An Expert Panel. Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
B M Bonora, G Russo, F Leonetti, M Strazzabosco, L Nollino, G Aimaretti, A Giaccari, F Broglio, A Consoli, A Avogaro, Gian Poalo Fadini, null null
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study. Journal of endocrinological investigation 47 (6) (2024)
Guillermo E Umpierrez, Georgia M Davis, Nuha A ElSayed, Gian Poalo Fadini, Rodolfo J Galindo, Irl B Hirsch, David C Klonoff, Rozalina Grubina McCoy, Shivani Misra, Robert A Gabbay, Raveendhara R Bannuru, Ketan K Dhatariya
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes care 47 (8) (2024)
B M Bonora, G Russo, F Leonetti, M Strazzabosco, L Nollino, G Aimaretti, A Giaccari, F Broglio, A Consoli, A Avogaro, Gian Poalo Fadini, null null
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study. Journal of endocrinological investigation (2024)
Marella Marassi, Mario Luca Morieri, Viola Sanga, Giulio Ceolotto, Angelo Avogaro, Gian Poalo Fadini
The Elusive Nature of ABCC8-related Maturity-Onset Diabetes of the Young (ABCC8-MODY). A Review of the Literature and Case Discussion. Current diabetes reports (2024)
Lars Norgren, Norbert Weiss, Sigrid Nikol, John C Lantis, Manesh R Patel, Robert J Hinchliffe, Holger Reinecke, Hans Dieter Volk, Petra Reinke, Gian Poalo Fadini, Racheli Ofir, Daniel Rothenstein, Nitsan Halevy, Mitko Karagjozov, John H Rundback
PACE: randomized, controlled, multicentre, multinational, phase III study of PLX-PAD for critical limb ischaemia in patients unsuitable for revascularization: randomized clinical trial. The British journal of surgery 111 (2) (2024)
Guillermo E Umpierrez, Georgia M Davis, Nuha A ElSayed, Gian Poalo Fadini, Rodolfo J Galindo, Irl B Hirsch, David C Klonoff, Rozalina Grubina McCoy, Shivani Misra, Robert A Gabbay, Raveendhara R Bannuru, Ketan K Dhatariya
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes care 47 (8) (2024)
Marella Marassi, Mario Luca Morieri, Viola Sanga, Giulio Ceolotto, Angelo Avogaro, Gian Poalo Fadini
The Elusive Nature of ABCC8-related Maturity-Onset Diabetes of the Young (ABCC8-MODY). A Review of the Literature and Case Discussion. Current diabetes reports 24 (9) (2024)
Gian Poalo Fadini, Enrico Longato, Mario Luca Morieri, Enzo Bonora, Agostino Consoli, Bruno Fattor, Mauro Rigato, Federica Turchi, Stephano Del Prato, Angelo Avogaro, Anna Solini, null null
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care. Diabetologia (2024)
Gian Poalo Fadini, Benedetta Maria Bonora, Mariangela Ghiani, Roberto Anichini, Elena Melchionda, Bruno Fattor, Stefano Fazion, Giancarla Meregalli, Andrea Giaccari, Angelo Avogaro, Agostino Consoli, null null
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts. Diabetes, obesity & metabolism 26 (6) (2024)
Marella Marassi, Mario Luca Morieri, Viola Sanga, Giulio Ceolotto, Angelo Avogaro, Gian Poalo Fadini
The Elusive Nature of ABCC8-related Maturity-Onset Diabetes of the Young (ABCC8-MODY). A Review of the Literature and Case Discussion. Current diabetes reports 24 (9) (2024)
Riccardo Candido, Chiara Di Loreto, Paolo Desenzani, Paola Pantanetti, Cristina Romano, Silvio Settembrini, Sebastiano Bruno Solerte, Gian Poalo Fadini
Suitability and Usefulness of a Flexible Dosing Timing of Oral Semaglutide to Maximize Benefit in Clinical Practice: An Expert Panel. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Gian Poalo Fadini, Raffaella Buzzetti, Dario Pitocco, Elena Tortato, Alessia Scatena, Olga Lamacchia, Giusi Lastoria, Lucia Simoni, Agostino Consoli, null null
IDegLira for the real-world treatment of type 2 diabetes in Italy. Final results from the REX observational study. Diabetes, obesity & metabolism 26 (5) (2024)
Guillermo E Umpierrez, Georgia M Davis, Nuha A ElSayed, Gian Poalo Fadini, Rodolfo J Galindo, Irl B Hirsch, David C Klonoff, Rozalina Grubina McCoy, Shivani Misra, Robert A Gabbay, Raveendhara R Bannuru, Ketan K Dhatariya
Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia 67 (8) (2024)
Riccardo Candido, Chiara Di Loreto, Paolo Desenzani, Paola Pantanetti, Cristina Romano, Silvio Settembrini, Sebastiano Bruno Solerte, Gian Poalo Fadini
Suitability and Usefulness of a Flexible Dosing Timing of Oral Semaglutide to Maximize Benefit in Clinical Practice: An Expert Panel. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Jonathan Golledge, Shivshankar Thanigaimani, Kristen S Barratt, Gian Poalo Fadini
Recent developments in targets for ischemic foot disease. Diabetes/metabolism research and reviews (2023)
Mauro Rigato, Gian Poalo Fadini, Angelo Avogaro
Safety of sodium-glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Diabetes, obesity & metabolism (2023)
Gian Poalo Fadini, Mario Luca Morieri
Deciphering dementia in the cardiometabolic continuum. European heart journal 44 (7) (2023)
Francesca Dassie, Mattia Albiero, Silvia Bettini, Roberta Cappellari, Gabriella Milan, Stefano Ciciliot, Jurgen K Naggert, Angelo Avogaro, Roberto Vettor, Pietro Maffei, Gian Poalo Fadini
Hematopoietic Stem Cells and Metabolic Deterioration in Alström Syndrome, a Rare Genetic Model of the Metabolic Syndrome. Endocrinology 164 (3) (2023)
Mattia Albiero, Stefano Ciciliot, Anna Rodella, Ludovica Migliozzi, Francesco Ivan Amendolagine, Carlotta Boscaro, Gaia Zuccolotto, Antonio Rosato, Gian Poalo Fadini
Loss of Hematopoietic Cell-Derived Oncostatin M Worsens Diet-Induced Dysmetabolism in Mice. Diabetes 72 (4) (2023)
Francesca Dassie, Mattia Albiero, Silvia Bettini, Roberta Cappellari, Gabriella Milan, Stefano Ciciliot, Jurgen K Naggert, Angelo Avogaro, Roberto Vettor, Pietro Maffei, Gian Poalo Fadini
Hematopoietic stem cells and metabolic deterioration in Alström syndrome, a rare genetic model of the metabolic syndrome. Endocrinology (2023)
B M Bonora, R Cappellari, M Albiero, L Prevedello, M Foletto, R Vettor, A Avogaro, Gian Poalo Fadini
Putative circulating adipose tissue-derived stem cells, obesity, and metabolic syndrome features. Journal of endocrinological investigation (2023)
Mattia Albiero, Stefano Ciciliot, Anna Rodella, Ludovica Migliozzi, Francesco Ivan Amendolagine, Carlotta Boscaro, Gaia Zuccolotto, Antonio Rosato, Gian Poalo Fadini
Loss of Hematopoietic Cell-Derived Oncostatin M Worsens Diet-Induced Dysmetabolism in Mice. Diabetes 72 (4) (2023)
Benedetta Maria Bonora, Mario Luca Morieri, Marella Marassi, Roberta Cappellari, Angelo Avogaro, Gian Poalo Fadini
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells. Diabetologia (2023)
M L Morieri, I Raz, A Consoli, M Rigato, A Lapolla, F Broglio, E Bonora, A Avogaro, Gian Poalo Fadini, null null
Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study. Journal of endocrinological investigation (2023)
Francesca Dassie, Mattia Albiero, Silvia Bettini, Roberta Cappellari, Gabriella Milan, Stefano Ciciliot, Jurgen K Naggert, Angelo Avogaro, Roberto Vettor, Pietro Maffei, Gian Poalo Fadini
Hematopoietic Stem Cells and Metabolic Deterioration in Alström Syndrome, a Rare Genetic Model of the Metabolic Syndrome. Endocrinology 164 (3) (2023)
Mario Luca Morieri, Riccardo Candido, Simona Frontoni, Olga Disoteo, Anna Solini, Gian Poalo Fadini, null null
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Mario Luca Morieri, Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Angelo Avogaro, Gian Poalo Fadini
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care. Cardiovascular diabetology 21 (1) (2022)
Mario Luca Morieri, Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Angelo Avogaro, Gian Poalo Fadini
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care. Cardiovascular diabetology 21 (1) (2022)
Francesca Mannucci, Giacomo Vitturi, Luca Benacchio, Luca Gino Sbrogiò, Francesca Bano, Annunziata Lapolla, Francesco Piarulli, Maria Cecilia Giron, Angelo Avogaro, Gian Poalo Fadini
Infection Rates and Impact of Glucose Lowering Medications on the Clinical Course of COVID-19 in People with Type 2 Diabetes: A Retrospective Observational Study. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Gian Poalo Fadini, F Boscari, D Falaguasta, S Ferretto, A Maran, A Avogaro, D Bruttomesso
Glycemic control after switching to faster aspart in adults with type 1 diabetes. Journal of endocrinological investigation 45 (6) (2022)
Benedetta Maria Bonora, Roberta Cappellari, Marco Grasso, Marta Mazzucato, Marianna D'Anna, Angelo Avogaro, Gian Poalo Fadini
Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 13 (7) (2022)
Gian Poalo Fadini
Perturbation of Glucose Homeostasis During Acute Illness: Stress Hyperglycemia and Relative Hypoglycemia. Diabetes care 45 (4) (2022)
Gian Poalo Fadini, Mario Luca Morieri
Deciphering dementia in the cardiometabolic continuum. European heart journal (2022)
Mario Luca Morieri, Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Angelo Avogaro, Gian Poalo Fadini
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care. Cardiovascular diabetology 21 (1) (2022)
Shafeeq A Mohammed, Mattia Albiero, Samuele Ambrosini, Era Gorica, Gergely Karsai, Carlo M Caravaggi, Stefano Masi, Giovanni G Camici, Florian A Wenzl, Vincenzo Calderone, Paolo Madeddu, Sebastiano Sciarretta, Christian M Matter, Gaia Spinetti, Thomas F Lüscher, Frank Ruschitzka, Sarah Costantino, Gian Poalo Fadini, Francesco Paneni
The BET Protein Inhibitor Apabetalone Rescues Diabetes-Induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1. Antioxidants & redox signaling 36 (10-12) (2022)
Gian Poalo Fadini, Raffaella Buzzetti, Maria Rosa Fittipaldi, Ferruccio D'Incau, Andrea Da Porto, Angela Girelli, Lucia Simoni, Giusi Lastoria, Agostino Consoli, null null
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 13 (8) (2022)
Mario Luca Morieri, Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Angelo Avogaro, Gian Poalo Fadini
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care. Cardiovascular diabetology 21 (1) (2022)
Saula Vigili de Kreutzenberg, Alessandra Giannella, Giulio Ceolotto, Elisabetta Faggin, Roberta Cappellari, Marta Mazzucato, Chiara Fraccaro, Giuseppe Tarantini, Angelo Avogaro, Gian Poalo Fadini
A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular disease. Diabetologia 65 (9) (2022)
Mario Luca Morieri, Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Angelo Avogaro, Gian Poalo Fadini
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care. Cardiovascular diabetology 21 (1) (2022)
Gian Poalo Fadini, Cristobal Morales, Irene Caballero, Beatriz González, Nikolaos Tentolouris, Agostino Consoli
Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World Analysis. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Mario Luca Morieri, Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Angelo Avogaro, Gian Poalo Fadini
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care. Cardiovascular diabetology 21 (1) (2022)
Gian Poalo Fadini, Mattia Albiero
Impaired Hematopoietic Stem/Progenitor Cell Traffic and Multi-organ Damage in Diabetes. Stem cells (Dayton, Ohio) 40 (8) (2022)
Benedetta Maria Bonora, Paola Fogar, Jenny Zuin, Daniele Falaguasta, Roberta Cappellari, Annamaria Cattelan, Serena Marinello, Anna Ferrari, Angelo Avogaro, Mario Plebani, Daniela Basso, Gian Poalo Fadini
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19. Diabetes 71 (4) (2022)
Alberto Maran, Mario Luca Morieri, Daniele Falaguasta, Angelo Avogaro, Gian Poalo Fadini
The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes. Diabetes care 45 (10) (2022)
V Sciannameo, P Berchialla, A Avogaro, Gian Poalo Fadini, null null
Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes. Cardiovascular diabetology 20 (1) (2021)
Mattia Albiero, Serena Tedesco, Francesco Ivan Amendolagine, Marianna D'Anna, Ludovica Migliozzi, Gaia Zuccolotto, Antonio Rosato, Roberta Cappellari, Angelo Avogaro, Gian Poalo Fadini
Inhibition of SGLT2 Rescues Bone Marrow Cell Traffic for Vascular Repair: Role of Glucose Control and Ketogenesis. Diabetes 70 (8) (2021)
Gian Poalo Fadini, Saula Vigili de Kreutzenberg, Angelo Avogaro
Where diabetes care meets cardiovascular research: our cardiovascular perspective at a Centre devoted to diabetes research and care. European heart journal 42 (25) (2021)
M L Morieri, N Vitturi, A Avogaro, G Targher, Gian Poalo Fadini, null null
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care. Journal of endocrinological investigation 44 (9) (2021)
Benedetta Maria Bonora, Mattia Albiero, Mario Luca Morieri, Roberta Cappellari, Francesco Ivan Amendolagine, Marta Mazzucato, Alberto Zambon, Elisabetta Iori, Angelo Avogaro, Gian Poalo Fadini
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial. Diabetologia 64 (10) (2021)
B M Bonora, A Avogaro, Gian Poalo Fadini
Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis. Journal of endocrinological investigation 44 (7) (2021)
Silvano Fasolato, Mariagrazia Ruvoletto, Giorgia Nardo, Andrea Rasola, Marco Sciacovelli, Giacomo Zanus, Cristian Turato, Santina Quarta, Liliana Terrin, Gian Poalo Fadini, Giulio Ceolotto, Maria Guido, Umberto Cillo, Stefano Indraccolo, Paolo Bernardi, Patrizia Pontisso
Low P66shc with High SerpinB3 Levels Favors Necroptosis and Better Survival in Hepatocellular Carcinoma. Biology 10 (5) (2021)
Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Lorenzo Gubian, Angelo Avogaro, Gian Poalo Fadini
Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life. BMJ open diabetes research & care 8 (1) (2021)
Othmar Moser, Christoph Sternad, Max L Eckstein, Agnieszka Szadkowska, Arkadiusz Michalak, Julia Katharina Mader, Haris Ziko, Hesham Elsayed, Felix Aberer, Agnes Sola-Gazagnes, Etienne Larger, Gian Poalo Fadini, Benedetta Maria Bonora, Daniela Bruttomesso, Federico Boscari, Guido Freckmann, Stefan Pleus, Sverre C Christiansen, Harald Sourij
Performance of intermittently scanned continuous glucose monitoring (isCGM) systems in people with type 1 diabetes: a pooled analysis. Diabetes, obesity & metabolism (2021)
Gian Poalo Fadini, B M Bonora, M L Morieri, A Avogaro
Why diabetes outpatient clinics should not close during pandemic crises. Journal of endocrinological investigation 44 (8) (2021)
Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro, Gian Poalo Fadini
Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study. Cardiovascular diabetology 20 (1) (2021)
Riccardo Senter, Federico Capone, Stefano Pasqualin, Lorenzo Cerruti, Leonardo Molinari, Elisa Fonte Basso, Nicolò Zanforlin, Lorenzo Previato, Alessandro Toffolon, Caterina Sensi, Gaetano Paride Arcidiacono, Davide Gorgi, Renato Ippolito, Enrico Nessi, Pietro Pettenella, Andrea Cellini, Claudio Fossa, Eleonora Vania, Samuele Gardin, Andi Sukthi, Dora Luise, Maria Teresa Giordani, Mirko Zanatta, Sandro Savino, Vito Cianci, Andrea Sattin, Anna Maria Cattelan, Andrea Vianello, Raffaele Pesavento, Sandro Giannini, Angelo Avogaro, Roberto Vettor, Gian Poalo Fadini, Alois Saller
Lung Ultrasound Patterns and Clinical-Laboratory Correlates during COVID-19 Pneumonia: A Retrospective Study from North East Italy. Journal of clinical medicine 10 (6) (2021)
Enzo Bonora, Salvatore Cataudella, Giulio Marchesini, Roberto Miccoli, Olga Vaccaro, Gian Poalo Fadini, Nello Martini, Elisa Rossi, null null
Clinical burden of diabetes in Italy in 2018: a look at a systemic disease from the ARNO Diabetes Observatory. BMJ open diabetes research & care 8 (1) (2021)
Arianna Scalco, Cristina Liboni, Roberta Angioni, Anna Di Bona, Mattia Albiero, Nicole Bertoldi, Gian Poalo Fadini, Gaetano Thiene, Stephen P Chelko, Cristina Basso, Antonella Viola, Marco Mongillo, Tania Zaglia
Arrhythmogenic Cardiomyopathy Is a Multicellular Disease Affecting Cardiac and Bone Marrow Mesenchymal Stromal Cells. Journal of clinical medicine 10 (9) (2021)
Benedetta Maria Bonora, Emanuel Raschi, Angelo Avogaro, Gian Poalo Fadini
SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system. Cardiovascular diabetology 20 (1) (2021)
Gian Poalo Fadini, Olga Disoteo, Riccardo Candido, Paolo Di Bartolo, Luigi Laviola, Agostino Consoli
Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies. Diabetes therapy : research, treatment and education of diabetes and related disorders 12 (3) (2021)
Gian Poalo Fadini, Stephano Del Prato, Angelo Avogaro, Anna Solini
Challenges and opportunities in real-world evidence on the renal effects of sodium-glucose cotransporter-2 inhibitors. Diabetes, obesity & metabolism (2021)
Agostino Consoli, Leszek Czupryniak, Rui Duarte, György Jermendy, Alexandra Kautzky-Willer, Chantal Mathieu, Miguel Melo, Lawrence A Leiter, Frank Nobels, Nikoloas Papanas, Gabriela Roman, Oliver Schnell, Alexis Sotiropoulos, Coen D A Stehouwer, Cornelis Cees J Tack, Vincent Woo, Gian Poalo Fadini, Itamar Raz
Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel. Diabetes, obesity & metabolism 22 (10) (2020)
Veronica Sciannameo, Paola Berchialla, Emanuela Orsi, Olga Lamacchia, Susanna Morano, Fabrizio Querci, Agostino Consoli, Angelo Avogaro, Gian Poalo Fadini, null null
Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice: The case of glucagon-like peptide-1 receptor agonists. Diabetes, obesity & metabolism 22 (5) (2020)
Roberta Cappellari, Marianna D'Anna, Lisa Menegazzo, Benedetta Maria Bonora, Mattia Albiero, Angelo Avogaro, Gian Poalo Fadini
Diabetes mellitus impairs circulating proangiogenic granulocytes. Diabetologia 63 (9) (2020)
Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro, Gian Poalo Fadini
Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice. Cardiovascular diabetology 19 (1) (2020)
Benedetta Maria Bonora, Mario Luca Morieri, Angelo Avogaro, Gian Poalo Fadini
The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy. Diabetes care 44 (1) (2020)
Benedetta Maria Bonora, Roberta Cappellari, Marta Mazzucato, Mauro Rigato, Marco Grasso, Mirko Menegolo, Andrea Bruttocao, Angelo Avogaro, Gian Poalo Fadini
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trial. Stem cells translational medicine 9 (9) (2020)
Benedetta Maria Bonora, Angelo Avogaro, Gian Poalo Fadini
Euglycemic Ketoacidosis. Current diabetes reports 20 (7) (2020)
Mario Luca Morieri, Agostino Consoli, Giorgio Sesti, Francesco Purrello, Angelo Avogaro, Gian Poalo Fadini, null null
Comparative effectiveness of dapagliflozin vs DPP-4 inhibitors on a composite endpoint of HbA1c, body weight and blood pressure reduction in the real world. Diabetes/metabolism research and reviews 37 (1) (2020)
Gian Poalo Fadini, Mario Luca Morieri, Enrico Longato, Benedetta Maria Bonora, Silvia Pinelli, Elisa Selmin, Giacomo Voltan, Daniele Falaguasta, Silvia Tresso, Giorgia Costantini, Giovanni Sparacino, Barbara Di Camillo, Lara Tramontan, Anna Maria Cattelan, Andrea Vianello, Paola Fioretto, Roberto Vettor, Angelo Avogaro
Exposure to dipeptidyl-peptidase-4 inhibitors and COVID-19 among people with type 2 diabetes: A case-control study. Diabetes, obesity & metabolism 22 (10) (2020)
Emanuel Raschi, Gian Poalo Fadini, Igor Diemberger, Elisabetta Poluzzi, Fabrizio de Ponti
SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR? Expert opinion on pharmacotherapy 22 (5) (2020)
Mario Luca Morieri, Benedetta Maria Bonora, Enrico Longato, Barbara Di Camilo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro, Gian Poalo Fadini
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysis. Diabetes, obesity & metabolism 22 (10) (2020)
Serena Tedesco, Stefano Ciciliot, Lisa Menegazzo, Marianna D'Anna, Valentina Scattolini, Roberta Cappellari, Andrea Cignarella, Angelo Avogaro, Mattia Albiero, Gian Poalo Fadini
Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes. Diabetes 69 (7) (2020)
Benedetta Maria Bonora, Federico Boscari, Angelo Avogaro, Daniela Bruttomesso, Gian Poalo Fadini
Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy. Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)
Gian Poalo Fadini, Carla Giordano, Laura Salvi, Antonio Nicolucci, null null
Reduced Rates of Hypoglycemia in Type 1 or Type 2 Diabetes After Switching to Insulin Degludec: Results from the Italian Cohort of the ReFLeCT Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 11 (12) (2020)
Gian Poalo Fadini, P Li Volsi, E Devangelio, M Poli, G Cazzetta, G Felace, A Avogaro, null null
Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study. Journal of endocrinological investigation 43 (3) (2019)
Gian Poalo Fadini, Mayur Sarangdhar, Fabrizio De Ponti, Angelo Avogaro, Emanuel Raschi
Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors. BMJ open diabetes research & care 7 (1) (2019)
Gian Poalo Fadini, Veronica Sciannameo, Ivano Franzetti, Daniele Bottigliengo, Paola D'Angelo, Carmela Vinci, Paola Berchialla, Salvatore Arena, Raffaella Buzzetti, Angelo Avogaro, null null
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study. Diabetes, obesity & metabolism 21 (8) (2019)
Mario Luca Morieri, Mauro Rigato, Vera Frison, Natalino Simioni, Michele D'Ambrosio, Federica Tadiotto, Agostino Paccagnella, Annunziata Lapolla, Angelo Avogaro, Gian Poalo Fadini
Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study. Diabetes, obesity & metabolism 21 (11) (2019)
Benedetta Maria Bonora, Saula Vigili de Kreutzenberg, Angelo Avogaro, Gian Poalo Fadini
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial. Cardiovascular diabetology 18 (1) (2019)
B M Bonora, A Avogaro, Gian Poalo Fadini
Effects of exenatide long-acting release on cardiovascular events and mortality in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Acta diabetologica 56 (9) (2019)
Angelo Avogaro, Gian Poalo Fadini, Stephano Del Prato
Reinterpreting Cardiorenal Protection of Renal Sodium-Glucose Cotransporter 2 Inhibitors via Cellular Life History Programming. Diabetes care 43 (3) (2019)
Mattia Albiero, Stefano Ciciliot, Serena Tedesco, Lisa Menegazzo, Marianna D'Anna, Valentina Scattolini, Roberta Cappellari, Gaia Zuccolotto, Antonio Rosato, Andrea Cignarella, Marco Giorgio, Angelo Avogaro, Gian Poalo Fadini
Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling Pathway. Diabetes 68 (6) (2019)

Gian Poalo Fadini.css-eqlu8i{font-size:small;padding-left:4px;} (G P Fadini, Gian Paolo Fadini)

Publication Activity (10 Years)

Top Topics

Top Venues

Gian Poalo Fadini (G P Fadini, Gian Paolo Fadini)